In-Licensing Projects
Manage and track all in-licensing opportunities, from evaluation to active agreement.
Total Value
$3.8M
Of projects in view
Active Agreements
4
In current view
Projects Displayed
8
Matching current filters
In-License of Paracetamol 500mg Dossier
Genericorp Labs
ID: PXG-LIC-2024-001
Start: 2024-01-15
End: 2025-01-14
Notice: 2024-10-15
Ibuprofen 400mg Softgel Partnership
BioInnovate Solutions
ID: PXG-LIC-2023-015
Start: 2023-09-01
End: 2028-08-31
Notice: 2028-05-31
Cetirizine 10mg Syrup Dossier Evaluation
Pioneer Pharma
ID: PXG-LIC-2024-002
Start: 2024-03-10
End: Open
Notice: N/A
Loratadine API Supply Agreement
Active Ingredients AG
Start: 2022-11-01
End: 2025-10-31
Notice: 2025-07-31
Omeprazole 20mg Delayed-Release Capsule
Genericorp Labs
Start: 2024-02-20
End: 2024-05-20
Notice: N/A
Vitamin D3 Oral Spray Licensing
BioInnovate Solutions
ID: PXG-LIC-2024-003
Start: 2024-04-01
End: 2029-03-31
Notice: 2028-12-31
Aspirin 100mg Supply Contract
Active Ingredients AG
Start: 2021-01-01
End: 2024-12-31
Notice: 2024-09-30
Hyaluronic Acid Serum Co-Branding
APAC Health Solutions
Start: 2024-05-15
End: 2027-05-14
Notice: 2027-02-14
0 of 8 row(s) selected.